论文部分内容阅读
目的观察血府逐瘀胶囊治疗结核性渗出性胸膜炎引起的胸膜肥厚。方法抗结核治疗,同时患侧胸腔注入尿激酶治疗渗出性积液后,加服血府逐瘀胶囊治疗,观察了49例患者。结果治疗组49例,41例轻、中度胸膜肥厚,占83.67%,重度胸膜肥厚8例,占16.33%;对照组36例,19例轻、中度胸膜肥厚,占52.78%,重度胸膜肥厚17例,占47.22%。两组比较,差异非常显著(P<0.01)。结论尿激酶加服血府逐瘀胶囊可明显减轻结核性渗出性胸腔积液引起的胸膜肥厚。
Objective To observe the treatment of pleural effusion caused by tuberculous exudative pleurisy by Xuefuzhuyu capsule. Methods Anti-TB treatment, while ipsilateral pleural injection of urokinase treatment exudative effusion, plus serving Xuefu Zhuyu capsule treatment, 49 patients were observed. Results In the treatment group, there were 49 cases, 41 cases of mild and moderate pleural hypertrophy, accounting for 83.67%, 8 cases of severe pleural hypertrophy, accounting for 16.33%; 36 cases of control group, 19 cases of mild and moderate pleural hypertrophy, accounting for 52.78%, severe pleural hypertrophy 17 cases, accounting for 47.22%. The differences between the two groups were significant (P <0.01). Conclusions Urokinase plus Xuefu Zhuyu Capsule can obviously reduce pleural hypertrophy caused by tuberculous exudative pleural effusion.